New schizophrenia drug shows promise in safety extension trial
NCT ID NCT05741528
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at the safety of a new drug called SEP-363856 for people with schizophrenia who switched from their usual antipsychotic medication. 75 participants who completed a prior study were followed for up to 25 weeks. The main goal was to track any side effects or serious health issues. This is a disease control study because schizophrenia requires ongoing management.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Anaheim, California, 92805, United States
-
Research Site
Bellflower, California, 90706, United States
-
Research Site
Garden Grove, California, 92845, United States
-
Research Site
Lemon Grove, California, 91945, United States
-
Research Site
Santee, California, 92071, United States
-
Research Site
Torrance, California, 90502, United States
-
Research Site
Hollywood, Florida, 33021, United States
-
Research Site
Miami, Florida, 33122, United States
-
Research Site
Atlanta, Georgia, 30318, United States
-
Research Site
Atlanta, Georgia, 30331, United States
-
Research Site
Chicago, Illinois, 60640, United States
-
Research Site
Gaithersburg, Maryland, 20877, United States
-
Research Site
Berlin, New Jersey, 08009, United States
-
Research Site
Charlotte, North Carolina, 28211, United States
-
Research Site
Hickory, North Carolina, 28601, United States
-
Research Site
Richardson, Texas, 75080, United States